3:19 PM
 | 
Mar 12, 2018
 |  BC Extra  |  Company News

Nektar joining S&P 500

Nektar Therapeutics (NASDAQ:NKTR) is joining the Standard & Poor’s 500 index, effective March 19.

The news...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >